According to a new market report published by Lucintel, the future of the global stent market looks promising with opportunities in the segments of hospital and ambulatory surgical centers. The global stent market is expected to reach an estimated $10.8 billion by 2024 with a CAGR of 3.3% from 2019 to 2024. The major growth drivers for this market are increasing interventional cardiology and peripheral vascular procedures and rising adoption of technological advancements in an effort to reduce treatment duration for high risk conventional surgical patients.
Browse 77 market data tables and 118 figures spread through 188 pages and in-depth TOC on “Global Stent Market”
Free customization on reports https://www.lucintel.com/stents-market.aspx
In this market, different types of stent such as coronary stent and peripheral vascular stent are used as product type. On the basis of comprehensive research, Lucintel forecasts that the coronary stent segment will show above average growth during the forecast period due to increasing cases of cardiovascular disorders.
Within the global stent market, the drug eluting stent segment will remain the largest market by technology during the forecast period due to low restenosis rate after surgery. Bioreabsorbable stent is expected to witness the highest growth during the forecast period due to its property of getting absorbed in the body.
Download Free PDF Brochure @ https://www.lucintel.com/stents-market.aspx#/
North America is expected to remain the largest market during the forecast period mainly due to its well-developed healthcare infrastructure and continued technological advancements across the healthcare industry.
Pre-Purchase Query @ https://www.lucintel.com/stents-market.aspx#/
Emerging trends which have a direct impact on the dynamics of the stent market include increasing use of bioreabsorbable stent, increasing adoption of co-polymers as raw materials, and increasing adoption of bifurcated stents. Abbott Laboratory, Boston Scientific, Medtronic public limited company, C R Bard, Cook Medical Inc., Terumo Corporation, and Cardinal Health Inc. and others are among the major stent manufacturers.
Lucintel, a leading global strategic consulting and market research firm, has analyzed the global stent market by product type, material, technology, end use, and region and has come up with a comprehensive research report entitled “Growth Opportunities in the Global Stent Market 2019-2024: Trends, Forecast, and Opportunity Analysis.” The Lucintel report serves as a catalyst for growth strategy as it provides a comprehensive data and analysis on trends, key drivers, and directions. The study includes a forecast for the global stent market by product type, material, technology, end use, and region as follows:
By Product Type [Value ($ Million) and Volume (Million Units) from 2013 to 2024]:
- Coronary Stents
- Peripheral Vascular Stents
By Technology [Value ($ Million) and Volume (Million Units) from 2013 to 2024]:
- Bare Metal Stents
- Drug Eluting Stents
- Bioreabsorbable Stents
By Material [Value ($ Million) and Volume (Million Units) from 2013 to 2024]:
By End Use [Value ($ Million)]:
- Ambulatory Surgical Center
By Region [Value ($ Million) and Volume (Million Units) from 2013 to 2024]:
- North America
– United States
– United Kingdom
- Asia Pacific
- The Rest of the World
Download Free Sample Page @ https://www.lucintel.com/stents-market.aspx#/
This 188-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link https://www.lucintel.com/stents-market.aspx or firstname.lastname@example.org.
Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.
This report answers following 11 key questions:
Q.1 What are some of the most promising, high-growth opportunities for the global stent market by product type (coronary stent and peripheral vascular stent), material (metal and polymer), technology (bare metal stent, drug eluting stent, and bioreabsorbable stent), end use (hospital and ambulatory surgical center), and by region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q. 2 Which segments will grow at a faster pace and why?
Q.3 Which regions will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the market?
Q.5 What are the business risks and threats to the market?
Q.6 What are the emerging trends in this market and reasons behind them?
Q.7 What are some changing demands of customers in the market?
Q.8 What are the new developments in the market? Which companies are leading these developments?
Q.9 Who are the major players in this market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this area and how big of a threat do they pose for loss of market share via product substitution?
Q.11 What M&A activity has occurred in the last 5 years?
Company Name: Lucintel
Contact Person: Tushita Roy
Email: Send Email
Address:Lucintel, 8951 Cypress Waters Blvd., Suite 160, Dallas
State: TX 75019
Country: United States